Copyright Policy And The Right To Science And Culture 09/02/2015 by Intellectual Property Watch 2 Comments Reposted from Afro-IP and infojustice.org: A report entitled ‘Copyright policy and the right to science and culture’ authored by the UN Special Rapporteur in the field of cultural rights, Farida Shaheed, has been released, writes Prof. Carolyn Ncube.
ANEPI IP News: Tres Cerveceros Y Una Marca (Three Brewers And A Brand) 09/02/2015 by Intellectual Property Watch, Intellectual Property Watch Leave a Comment Welcome to (ANEPI), the first Intellectual Property News Agency of Ecuador. The Agencia de Noticias Especializada en Propiedad Intelectual (ANEPI) publishes news, analysis, interviews, feature articles, a weekly update and more on Ecuador and the region, at http://www.anepi.ec. Articles are primarily in Spanish with some translation. Bienvenido a (ANEPI), La Primera Agencia de Noticias de […]
Year Ahead: Key IP-Related Issues, Dates At The WTO In 2015 09/02/2015 by Elena Bourtchouladze for Intellectual Property Watch Leave a Comment This year is shaping up to be a busy one for the World Trade Organization, and intellectual property issues are among those coming up.
US Challenges For Biotech In 2015 – An Interview With BIO’s Hans Sauer 06/02/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment The biotechnology industry is closely watching developments in the United States that could impact the industry in 2015. These include the regulatory framework for biosimilars, possible patent legislation, post-grant review procedure, and the consequences of the recent Supreme Court ruling banning the patenting of human genes. Hans Sauer, Deputy General Counsel for Intellectual Property at the Biotechnology Industry Organization (BIO), recently spoke with Intellectual Property Watch’s Catherine Saez. Sauer was asked to lay out the main developments to watch in the coming year.
South Africa Supreme Court Of Appeal Losing Its Shape 05/02/2015 by Intellectual Property Watch Leave a Comment South Africa’s Supreme Court of Appeal has been blessed for the past few decades by having in its ranks judges who have experience and expertise in the field of Intellectual Property Law, writes law professor Owen Dean. With the recent retirement of Louis Harms, the bench at the Supreme Court of Appeal has been denuded of judges who can be regarded as IP experts. The paucity of IP experience on the bench is regrettably beginning to show. In recent times the Supreme Court of Appeal has given three IP judgments in trade mark cases which, it is respectfully submitted, have been wrongly decided and are not in harmony with the principles of trade mark law and practice, Dean argues.
Unlimited Potential: The Innovation Renaissance Is Now 05/02/2015 by Intellectual Property Watch, Intellectual Property Watch 2 Comments By Patrick Kilbride At no other time in history has humanity enjoyed such a boundless period of innovation. The human experience is literally changing day-to-day as new medicines and new technologies create solutions to seemingly insurmountable global challenges such as poverty, hunger, disease, and climate change. This 21st century innovation renaissance could not be more […]
Questions About Funding, Text Of Tufts Study On Drug Costs 03/02/2015 by Intellectual Property Watch Leave a Comment The Union for Affordable Cancer Treatment has sent a letter to the author of a much-noted Tufts University (US) study that found high development costs for medicines, with copies to the university administration. The letter requests transparency on the funding of the study and the press conference announcing the results, as well as copies of the study itself, which the group says was not made public, along with details to justify the result.
The Latest News In Intellectual Property From ANEPI Ecuador 02/02/2015 by Intellectual Property Watch, Intellectual Property Watch Leave a Comment Welcome to (ANEPI), the first Intellectual Property News Agency of Ecuador. The Agencia de Noticias Especializada en Propiedad Intelectual (ANEPI) publishes news, analysis, interviews, feature articles, a weekly update and more on Ecuador and the region, at http://www.anepi.ec. Articles are primarily in Spanish with some translation. Bienvenido a (ANEPI), La Primera Agencia de Noticias de […]
Special Report: Will India Bend To US Pressure On IP Rights? 31/01/2015 by Patralekha Chatterjee for Intellectual Property Watch 5 Comments It is no secret that the United States has been scaling up pressure on India to adopt intellectual property measures similar to those common in the United States and the European Union. But to what extent does India’s new government led by the business-friendly Narendra Modi see eye to eye with US official position? Can India, the “pharmacy of the world”, resolve the friction between pharmaceutical patents and access to affordable medicines without putting off foreign investors? The vitriolic and polarising debate surrounding these questions has got a fresh lease of life following US President Barack Obama’s landmark three-day visit to India this week. While Indian and American business moguls are bullish about the future, Indian generic drug-makers as well as health activists within and outside India are deeply anxious about the shape of things to come
Looking Behind The Different Invalidation Rates Of Oppositions And IPRs 28/01/2015 by Intellectual Property Watch Leave a Comment Opposition proceedings in Europe have long served as a powerful tool for third parties to challenge the validity of a patent before the European Patent Office (EPO). Now, under the America Invents Act (effective September 2012), the United States (US) has two new procedures for challenging the validity of a patent before the US Patent and Trademark Office (USPTO): inter partes review (IPR) and post-grant review. Current statistics indicate a higher invalidation rate for IPRs as compared to EPO oppositions.